One significant risk factor that is considered to contribute to Kenya’s TB burden is HIV. TB is one of the most common opportunistic infections associated with HIV, and HIV infection increases the risk of developing active TB disease in individuals with latent TB infection. Due to their compromised immune systems, increased susceptibility to TB infection and latent TB reactivation, people with HIV have a higher probability of attaining TB. This study develops an age-stratified mathematical model with optimal control for co-infection of HIV and TB. The model’s reproduction number, as well as the equilibrium of endemic and disease-free states have been computed. Least Squares technique of minimization has be used to determine the model parameters. HIV antiretroviral therapy treatment adherence and tuberculosis treatment have been considered for optimization. Runge-Kutta 𝒪(h4) has been used to solve the system differential equations for its high accuracy and flexibility. Results from the numerical simulations show that ART adherence is the best intervention to control the co-infection in its earlier stages (HIV and latent TB). TB treatment is the best intervention for those affected with the coinfection on the later stage (HIV and active TB). Considering viral load suppression and TB prevention, viral load suppression is most effective for children and TB prevention is most effective for adults. The results of this research can be used by the Ministry of Health (MOH) for emphasis on most effective interventions as well as a basis study tool that can be recreated for other co-infections.
Published in | Applied and Computational Mathematics (Volume 14, Issue 1) |
DOI | 10.11648/j.acm.20251401.14 |
Page(s) | 37-63 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Age-stratified, Co-infection, Optimal Control
[1] | G. M. Shaw and E. Hunter, “Hiv transmission,” Cold Spring Harbor perspectives in medicine, vol. 2, no. 11, p. a006965, 2012. |
[2] | WHO, Global health sector strategies on, respectively, HIV,viralhepatitisandsexuallytransmittedinfectionsfor the period 2022-2030. World Health Organization, 2022. |
[3] | CDC, Tuberculosis, TB. No. 33, Department of Health, Education, and Welfare, Public Health Service, Centerâ, 1977. |
[4] | NIH et al., “Hiv and opportunistic infections, coinfections, and conditions,” 2022. |
[5] | WHO et al., “Who global lists of high burden countries for tuberculosis (tb), tb/hiv and multidrug/rifampicinresistant tb (mdr/rr-tb), 2021-2025: background document,” Cold Spring Harbor perspectives in medicine, 2021. |
[6] | M. Amuyunzu-Nyamongo, “Hiv/aids in kenya: Moving beyond policy and rhetoric,” African Sociological Review/Revue Africaine de Sociologie, vol. 5, no. 2, pp. 86-101, 2001. |
[7] | B. Tchakounte Youngui, B. K. Tchounga, S. M. Graham, and M. Bonnet, “Tuberculosis infection in children and adolescents,” Pathogens, vol. 11, no. 12, p. 1512, 2022. |
[8] | G. G. Katana, M. Ngari, T. Maina, D. Sanga, and O. A. Abdullahi, “Tuberculosis poor treatment outcomes and its determinants in kilifi county, kenya: a retrospective cohort study from 2012 to 2019,” Archives of Public Health, vol. 80, no. 1, pp. 1-13, 2022. |
[9] | S. Ali, A. A. Raina, J. Iqbal, and R. Mathur, “Mathematical modeling and stability analysis of hiv/aids-tb co-infection.,” Palestine Journal of Mathematics, vol. 8, no. 2, 2019. |
[10] | T. Getaneh, A. Negesse, G. Dessie, and M. Desta, “The impact of tuberculosis co-infection on virological failure among adults living with hiv in ethiopia: A systematic review and meta-analysis,” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, vol. 27, p. 100310, 2022. |
[11] | K. KENPHIA, “Kenya population-based hiv impact assessment,” Kenya Population-based HIV Impact Assessment. Accessed August 2022, vol. 14, 2022. |
[12] | S. Klemm and L. Ravera, “On sir-type epidemiological models and population heterogeneity effects,” Physica A: Statistical Mechanics and its Applications, vol. 624, p. 128928, 2023. |
[13] | C. Ozcaglar, A. Shabbeer, S. L. Vandenberg, B. Yener, and K. P. Bennett, “Epidemiological models of mycobacterium tuberculosis complex infections,” Mathematical biosciences, vol. 236, no. 2, pp. 77-96, 2012. |
[14] | C. Walker, “Well-posedness and stability analysis of an epidemic model with infection age and spatial diffusion,” Journal of Mathematical Biology, vol. 87, no. 3, p. 52, 2023. |
[15] | P. Van den Driessche and J. Watmough, “Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission,” Mathematical biosciences, vol. 180, no. 1-2, pp. 29- 48, 2002. |
[16] | R. Devaney, An introduction to chaotic dynamical systems. CRC press, 2018. |
[17] | E. X. DeJesus and C. Kaufman, “Routh-hurwitz criterion intheexaminationofeigenvaluesofasystemofnonlinear ordinary differential equations,” Physical Review A, vol. 35, no. 12, p. 5288, 1987. |
[18] | T. O. Orwa, R. W. Mbogo, and L. S. Luboobi, “Mathematical model for hepatocytic-erythrocytic dynamics of malaria,” International Journal of Mathematics and Mathematical Sciences, vol. 2018, no. 1, p. 7019868, 2018. |
[19] | T. O. Orwa, R. W. Mbogo, and L. S. Luboobi, “Multiplestrain malaria infection and its impacts on plasmodium falciparum resistance to antimalarial therapy: A mathematical modelling perspective,” Computational and Mathematical Methods in Medicine, vol. 2019, no. 1, p. 9783986, 2019. |
[20] | P. Van den Driessche and J. Watmough, “Further notes on the basic reproduction number,” Mathematical epidemiology, pp. 159-178, 2008. |
[21] | M. Zamir, G. Zaman, and A. S. Alshomrani, “Sensitivity analysis and optimal control of anthroponotic cutaneous leishmania,” PloS one, vol. 11, no. 8, p. e0160513, 2016. |
[22] | M. Das, G. Samanta, and M. De la Sen, “A fractional ordered covid-19 model incorporating comorbidity and vaccination,” Mathematics, vol. 9, no. 21, p. 2806, 2021. |
[23] | N. Chitnis, J. M. Hyman, and J. M. Cushing, “Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model,” Bulletin of mathematical biology, vol. 70, pp. 1272-1296, 2008. |
[24] | R. Aggarwal and Y. A. Raj, “A fractional order hivtb co- infection model in the presence of exogenous reinfection and recurrent tb,” Nonlinear Dynamics, vol. 104, pp. 4701-4725, 2021. |
[25] | “World Bank Open Data,” 2022. [Accessed 29-11-2024]. |
[26] | E. Omondi, R. Mbogo, and L. Luboobi, “Mathematical modelling of the impact of testing, treatment and control of hiv transmission in kenya,” Cogent Mathematics & Statistics, vol. 5, no. 1, p. 1475590, 2018. |
[27] | O. B. VINCENT, “A mathematical model of hiv and tb co-infection with interventions, a case of siaya county in kenya,” 2022. |
[28] | A. S. Ajiboye, “Tuberculosis preventive treatment updateâus presidentâs emergency plan for aids relief, 36 countries, 2016-2023,” MMWR. Morbidity and Mortality Weekly Report, vol. 73, 2024. |
[29] | L. B. Whiteley, E. M. Olsen, K. K. Haubrick, E. Odoom, N.Tarantino, andL.K.Brown, “Areviewofinterventions to enhance hiv medication adherence,” Current Hiv/Aids Reports, vol. 18, no. 5, pp. 443-457, 2021. |
[30] | T. K. Ayele, E. F. D. Goufo, and S. Mugisha, “Mathematical modeling of hiv/aids with optimal control: a case study in ethiopia,” Results in Physics, vol. 26, p. 104263, 2021. |
[31] | K. R. Cheneke, “Optimal control and bifurcation analysis of hiv model,” Computational and Mathematical Methods in Medicine, vol. 2023, no. 1, p. 4754426, 2023. |
[32] | L. Pontryagin et al., “The mathematical theory of optimal processes,(1962), chap. 2,” VI,JohnWilely&Sons, 1962. |
[33] | R. C. Patel, P. Oyaro, B. Odeny, I. Mukui, K. K. Thomas, M. Sharma, J. Wagude, E. Kinywa, F. Oluoch, F. Odhiambo, et al., “Optimizing viral load suppression in kenyan children on antiretroviral therapy (opt4kids),” Contemporary Clinical Trials Communications, vol. 20, p. 100673, 2020. |
[34] | I. Navasardyan, R. Miwalian, A. Petrosyan, S. Yeganyan, and V. Venketaraman, “Hiv-tb coinfection: Current therapeutic approaches and drug interactions,” Viruses, vol. 16, no. 3, p. 321, 2024. |
[35] | A. Bhatt, Z. Q. Syed, and H. Singh, “Converging epidemics: A narrative review of tuberculosis (tb) and human immunodeficiency virus (hiv) coinfection,” Cureus, vol. 15, no. 10, 2023. |
APA Style
Maina, R. M., Kinyanjui, M. N., Mwalili, S. M., Kioi, D. G. (2025). An Age-stratified Mathematical Model for Human Immunodeficiency Virus and Tuberculosis Co-infection with Optimal Control. Applied and Computational Mathematics, 14(1), 37-63. https://doi.org/10.11648/j.acm.20251401.14
ACS Style
Maina, R. M.; Kinyanjui, M. N.; Mwalili, S. M.; Kioi, D. G. An Age-stratified Mathematical Model for Human Immunodeficiency Virus and Tuberculosis Co-infection with Optimal Control. Appl. Comput. Math. 2025, 14(1), 37-63. doi: 10.11648/j.acm.20251401.14
@article{10.11648/j.acm.20251401.14, author = {Robert Mureithi Maina and Mathew Ngugi Kinyanjui and Samuel Musili Mwalili and Duncan Gathungu Kioi}, title = {An Age-stratified Mathematical Model for Human Immunodeficiency Virus and Tuberculosis Co-infection with Optimal Control}, journal = {Applied and Computational Mathematics}, volume = {14}, number = {1}, pages = {37-63}, doi = {10.11648/j.acm.20251401.14}, url = {https://doi.org/10.11648/j.acm.20251401.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.acm.20251401.14}, abstract = {One significant risk factor that is considered to contribute to Kenya’s TB burden is HIV. TB is one of the most common opportunistic infections associated with HIV, and HIV infection increases the risk of developing active TB disease in individuals with latent TB infection. Due to their compromised immune systems, increased susceptibility to TB infection and latent TB reactivation, people with HIV have a higher probability of attaining TB. This study develops an age-stratified mathematical model with optimal control for co-infection of HIV and TB. The model’s reproduction number, as well as the equilibrium of endemic and disease-free states have been computed. Least Squares technique of minimization has be used to determine the model parameters. HIV antiretroviral therapy treatment adherence and tuberculosis treatment have been considered for optimization. Runge-Kutta 𝒪(h4) has been used to solve the system differential equations for its high accuracy and flexibility. Results from the numerical simulations show that ART adherence is the best intervention to control the co-infection in its earlier stages (HIV and latent TB). TB treatment is the best intervention for those affected with the coinfection on the later stage (HIV and active TB). Considering viral load suppression and TB prevention, viral load suppression is most effective for children and TB prevention is most effective for adults. The results of this research can be used by the Ministry of Health (MOH) for emphasis on most effective interventions as well as a basis study tool that can be recreated for other co-infections.}, year = {2025} }
TY - JOUR T1 - An Age-stratified Mathematical Model for Human Immunodeficiency Virus and Tuberculosis Co-infection with Optimal Control AU - Robert Mureithi Maina AU - Mathew Ngugi Kinyanjui AU - Samuel Musili Mwalili AU - Duncan Gathungu Kioi Y1 - 2025/01/14 PY - 2025 N1 - https://doi.org/10.11648/j.acm.20251401.14 DO - 10.11648/j.acm.20251401.14 T2 - Applied and Computational Mathematics JF - Applied and Computational Mathematics JO - Applied and Computational Mathematics SP - 37 EP - 63 PB - Science Publishing Group SN - 2328-5613 UR - https://doi.org/10.11648/j.acm.20251401.14 AB - One significant risk factor that is considered to contribute to Kenya’s TB burden is HIV. TB is one of the most common opportunistic infections associated with HIV, and HIV infection increases the risk of developing active TB disease in individuals with latent TB infection. Due to their compromised immune systems, increased susceptibility to TB infection and latent TB reactivation, people with HIV have a higher probability of attaining TB. This study develops an age-stratified mathematical model with optimal control for co-infection of HIV and TB. The model’s reproduction number, as well as the equilibrium of endemic and disease-free states have been computed. Least Squares technique of minimization has be used to determine the model parameters. HIV antiretroviral therapy treatment adherence and tuberculosis treatment have been considered for optimization. Runge-Kutta 𝒪(h4) has been used to solve the system differential equations for its high accuracy and flexibility. Results from the numerical simulations show that ART adherence is the best intervention to control the co-infection in its earlier stages (HIV and latent TB). TB treatment is the best intervention for those affected with the coinfection on the later stage (HIV and active TB). Considering viral load suppression and TB prevention, viral load suppression is most effective for children and TB prevention is most effective for adults. The results of this research can be used by the Ministry of Health (MOH) for emphasis on most effective interventions as well as a basis study tool that can be recreated for other co-infections. VL - 14 IS - 1 ER -